| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0895994A2 Sulphonamide-substituted Pyranopyridines, process for their production and their use as a drug or diagnostics as well as medicaments containing them |
| 02/10/1999 | EP0895782A2 Pharmaceutical compositions of Cilansetron stabilized against racemisation |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207685A Novel medical use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 02/10/1999 | CN1207679A Use of cholinesterase inhibitors in treatment of xerostomia |
| 02/10/1999 | CN1207672A Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 02/10/1999 | CN1207391A Sulfonamide-substituted compounds, processes for their preparation, their use and medicament comprising them |
| 02/10/1999 | CN1207314A Chinese medicine for treating hepatitis B |
| 02/10/1999 | CN1207292A Stable anti-racemic medicinal preparation of cilancetlone |
| 02/10/1999 | CN1042031C Quaternary nitrogen-contg. phosphonate compounds, pharmaceutical compositions and use thereof |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869499 Benzyloxyquinuclidines as substance P antagonists |
| 02/09/1999 | US5869496 Treating asthma, emesis |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869059 Composition consisting of herb of genus equisetaceae and herb amphipterygium adstringens |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/05/1999 | CA2244577A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/05/1999 | CA2238673A1 Novel aminopeptidase |
| 02/04/1999 | WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 02/04/1999 | WO1999005113A1 Substituted 6-phenylphenanthridines |
| 02/04/1999 | WO1999005112A1 Substituted 6-alkylphenanthridines |
| 02/04/1999 | WO1999005111A1 Novel tetrazole derivatives |
| 02/04/1999 | WO1999005095A1 Aminocycloalkane compounds |
| 02/04/1999 | WO1999004804A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | WO1999004773A2 Method for inhibiting bone resorption |
| 02/04/1999 | DE19732903A1 Pellet-Formulierung zur Behandlung des Intestinaltraktes The pellet formulation for the treatment of the intestinal tract |
| 02/04/1999 | CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors |
| 02/04/1999 | CA2297183A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | CA2296329A1 Aminocycloalkane compounds |
| 02/03/1999 | EP0894862A2 Novel CysS |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 02/03/1999 | EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 02/03/1999 | EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 02/03/1999 | EP0893998A1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 02/03/1999 | CN1207097A Novel substituted 4-(1H-benzimidazol-2-YL) [1,4] diazepanes useful for the treatment of allergic diseases |
| 02/03/1999 | CN1207045A Nisin in combination with glycerol monolaurate active against helicobacter |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |
| 02/02/1999 | US5866593 Potent and selective phosphodiesterase type iv inhibitors, useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present. |
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866568 Heterocyclic compounds |
| 02/02/1999 | US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866329 Method and probe for detection of gene associated with liver neoplastic disease |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999003859A1 Novel spiroazabicyclic heterocyclic compounds |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/28/1999 | WO1999003486A1 Antacid and papain combination |
| 01/28/1999 | WO1999003444A1 Dental resin cements having improved handling properties |
| 01/28/1999 | WO1998046589A3 Indazole amide compounds as serotoninergic agents |
| 01/28/1999 | CA2295502A1 Dental resin cements having improved handling properties |
| 01/28/1999 | CA2286357A1 Antacid and papain combination |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892804A1 Isoxazolidine derivatives |
| 01/27/1999 | EP0892793A1 Substituted tetracyclic tetrahydrofuran derivatives |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0796243B1 Diaminocyclobutene-3,4-diones |
| 01/27/1999 | EP0669919B1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives |
| 01/27/1999 | CN1205895A Medicine for hepatosis and its preparation |
| 01/27/1999 | CN1205876A Compound medicine for gastroenteritis and gastroenteritic ulcer |
| 01/27/1999 | CN1041798C Synergistic combination of substance with gastric acid secretion inhibiting effect and acid degradable antibiotic |
| 01/26/1999 | US5864043 Cardiovascular disorders and angiotensin antagonist |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863947 Treating central nervous diseases such as neurological diseases, neurodegenerative diseases, and as antipsychotic, anticonvulsant, analgesic and antiemetic agents |
| 01/26/1999 | US5863924 5ht2b antagonist |
| 01/26/1999 | US5863923 Treatment of anxiety, psychosis, schizophrenia, drug abuse, irritable bowel syndrome |
| 01/26/1999 | US5863901 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders |
| 01/26/1999 | US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863551 Implantable polymer hydrogel for therapeutic uses |
| 01/26/1999 | CA2166901C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2136843C Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |